Delivery Order SPE2DB22D3301-SPE2DB24FZ0JM

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,379.99 firm fixed-price delivery order is for the supply of VARENICLINE 1 MG TABLET 56S, a medication used for smoking cessation. The contract has a completion date of May 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,447.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 1 mg tablets, a medication used in smoking cessation treatment. This is a Firm Fixed Price Delivery Order contract with a completion date of February 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is a delivery order with a ceiling value of $17,411.91, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Varenicline 1 mg tablets, a medication used to treat nicotine addiction. The contract has an ultimate completion date of June 28, 2023 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc.,...
This federal contract award, valued at $1,568.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 0.5 mg tablets, a medication used to treat nicotine addiction. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 and running through November 2026....
This federal contract award, valued at $1,871.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Varenicline 1 mg tablets, a medication used to treat nicotine addiction. The contract has a firm fixed price and an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.96, is for the delivery of 56 tablets of Varenicline 1 mg, a medication used for smoking cessation. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug Corp and the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, valued at $2,335.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 1 mg tablets, a medication used to treat nicotine addiction. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FA6Q5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,064.33 firm fixed-price delivery order is for the supply of Varenicline 1 mg tablets, a medication used in smoking cessation treatments. The contract has an ultimate completion date of March 12, 2024 and is not designated with any set-aside requirements, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract, valued at $1,806.76, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,866.18 firm fixed-price delivery order is for the supply of Varenicline 0.5 mg tablets, a medication used to treat nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ0JM
    Delivery Order

This $1,303.66 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Varenicline 1 mg tablets, a smoking cessation medication, to support government healthcare programs.

Amerisourcebergen holds two relevant Indefinite Delivery Contracts (IDCs) - one with the DLA valued up to $999,999,999.00 through 2025, and another with the Department of Justice Federal Bureau of Investigation valued up to $750,000 through 2024. These IDCs enable Amerisourcebergen to efficiently deliver a range of pharmaceutical products and medical supplies to various federal agencies and military facilities worldwide.

This particular award does not have a set-aside designation, indicating it was competed on a full and open basis. The contract has an ultimate completion date of July 12, 2024.

Generated 10/10/24, 9:15 AM